Related Content
Search Google Scholar for:
|
J. Cell Biol. 173 (4): 533-544
Copyright © 2006 by the Rockefeller University Press.
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Chad D. Knights1,
Jason Catania1,
Simone Di Giovanni1,
Selen Muratoglu2,
Ricardo Perez1,
Amber Swartzbeck1,
Andrew A. Quong3,
Xiaojing Zhang4,
Terry Beerman4,
Richard G. Pestell3, , and
Maria Laura Avantaggiati1
1 Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
2 Department of Pathology, Center for Vascular and Inflammatory Disease, University of Maryland, Baltimore, MD 21201
3 Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
4 Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14203
Correspondence to Maria Laura Avantaggiati: ma364{at}georgetown.edu
Abstract:
The activity of the p53 gene product is regulated by a plethora of posttranslational modifications. An open question is whether such posttranslational changes act redundantly or dependently upon one another. We show that a functional interference between specific acetylated and phosphorylated residues of p53 influences cell fate. Acetylation of lysine 320 (K320) prevents phosphorylation of crucial serines in the NH2-terminal region of p53; only allows activation of genes containing high-affinity p53 binding sites, such as p21/WAF; and promotes cell survival after DNA damage. In contrast, acetylation of K373 leads to hyperphosphorylation of p53 NH2-terminal residues and enhances the interaction with promoters for which p53 possesses low DNA binding affinity, such as those contained in proapoptotic genes, leading to cell death. Further, acetylation of each of these two lysine clusters differentially regulates the interaction of p53 with coactivators and corepressors and produces distinct gene-expression profiles. By analogy with the "histone code" hypothesis, we propose that the multiple biological activities of p53 are orchestrated and deciphered by different "p53 cassettes," each containing combination patterns of posttranslational modifications and proteinprotein interactions.
C.D. Knights and J. Catania contributed equally to this paper.
Abbreviations used in this paper: ChIP, chromatin immunoprecipitation; CPI, cyclopropylpyrroloindole; EMSA, electrophoretic mobility shift assay; PCAF, p300/CBP-associated factor; WT, wild-type.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons.
- C. Brochier, G. Dennis, M. A. Rivieccio, K. McLaughlin, G. Coppola, R. R. Ratan, and B. Langley (2013)
J. Neurosci.
33, 8621-8632
| Abstract »
| Full Text »
| PDF »
- Altered Binding Site Selection of p53 Transcription Cassettes by Hepatitis B Virus X Protein.
- C. Chan, Y. Wang, P. K. H. Chow, A. Y. F. Chung, L. L. P. J. Ooi, and C. G. Lee (2013)
Mol. Cell. Biol.
33, 485-497
| Abstract »
| Full Text »
| PDF »
- Xenobiotics and Loss of Cell Adhesion Drive Distinct Transcriptional Outcomes by Aryl Hydrocarbon Receptor Signaling.
- N. Hao, K. L. Lee, S. G. B. Furness, C. Bosdotter, L. Poellinger, and M. L. Whitelaw (2012)
Mol. Pharmacol.
82, 1082-1093
| Abstract »
| Full Text »
| PDF »
- Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
- A. Brandl, T. Wagner, K. M. Uhlig, S. K. Knauer, R. H. Stauber, F. Melchior, G. Schneider, T. Heinzel, and O. H. Kramer (2012)
J Mol Cell Biol
4, 284-293
| Abstract »
| Full Text »
| PDF »
- Resveratrol Stimulates Cortisol Biosynthesis by Activating SIRT-Dependent Deacetylation of P450scc.
- D. Li, E. B. Dammer, and M. B. Sewer (2012)
Endocrinology
153, 3258-3268
| Abstract »
| Full Text »
| PDF »
- Mechanisms of p53 activation and physiological relevance in the developing kidney.
- K. Aboudehen, S. Hilliard, Z. Saifudeen, and S. S. El-Dahr (2012)
Am J Physiol Renal Physiol
302, F928-F940
| Abstract »
| Full Text »
| PDF »
- Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements.
- J.-F. Millau, O. J. Bandele, J. Perron, N. Bastien, E. F. Bouchard, L. Gaudreau, D. A. Bell, and R. Drouin (2011)
Nucleic Acids Res.
39, 3053-3063
| Abstract »
| Full Text »
| PDF »
- Pleiotropic Effects of p300-mediated Acetylation on p68 and p72 RNA Helicase.
- S. M. Mooney, A. Goel, A. B. D'Assoro, J. L. Salisbury, and R. Janknecht (2010)
J. Biol. Chem.
285, 30443-30452
| Abstract »
| Full Text »
| PDF »
- HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity.
- A. Phillips, A. Teunisse, S. Lam, K. Lodder, M. Darley, M. Emaduddin, A. Wolf, J. Richter, J. de Lange, M. Verlaan-de Vries, et al. (2010)
J. Biol. Chem.
285, 29111-29127
| Abstract »
| Full Text »
| PDF »
- Transcriptional Regulation by P53.
- R. Beckerman and C. Prives (2010)
Cold Spring Harb Perspect Biol
2, a000935
| Abstract »
| Full Text »
| PDF »
- Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.
- J. Long, B. Parkin, P. Ouillette, D. Bixby, K. Shedden, H. Erba, S. Wang, and S. N. Malek (2010)
Blood
116, 71-80
| Abstract »
| Full Text »
| PDF »
- Dysregulation of Platelet-Derived Growth Factor {beta}-Receptor Expression by {Delta}Np73 in Neuroblastoma.
- D. Wetterskog, A. Moshiri, T. Ozaki, H. Uramoto, A. Nakagawara, and K. Funa (2009)
Mol. Cancer Res.
7, 2031-2039
| Abstract »
| Full Text »
| PDF »
- p53 Pre- and Post-Binding Event Theories Revisited: Stresses Reveal Specific and Dynamic p53-Binding Patterns on the p21 Gene Promoter.
- J.-F. Millau, N. Bastien, E. F. Bouchard, and R. Drouin (2009)
Cancer Res.
69, 8463-8471
| Abstract »
| Full Text »
| PDF »
- Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53.
- S. M. Sykes, T. J. Stanek, A. Frank, M. E. Murphy, and S. B. McMahon (2009)
J. Biol. Chem.
284, 20197-20205
| Abstract »
| Full Text »
| PDF »
- Identification of New p53 Acetylation Sites in COS-1 Cells.
- A. Joubel, R. J. Chalkley, K. F. Medzihradszky, H. Hondermarck, and A. L. Burlingame (2009)
Mol. Cell. Proteomics
8, 1167-1173
| Abstract »
| Full Text »
| PDF »
- Histone Deacetylase Inhibitors Prevent p53-Dependent and p53-Independent Bax-Mediated Neuronal Apoptosis through Two Distinct Mechanisms.
- T. Uo, T. D. Veenstra, and R. S. Morrison (2009)
J. Neurosci.
29, 2824-2832
| Abstract »
| Full Text »
| PDF »
- Chromatin Immunoprecipitation-on-Chip Reveals Stress-Dependent p53 Occupancy in Primary Normal Cells but Not in Established Cell Lines.
- H. Shaked, I. Shiff, M. Kott-Gutkowski, Z. Siegfried, Y. Haupt, and I. Simon (2008)
Cancer Res.
68, 9671-9677
| Abstract »
| Full Text »
| PDF »
- Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis.
- S. S. El-Dahr, K. Aboudehen, and S. Dipp (2008)
Am J Physiol Renal Physiol
295, F1404-F1413
| Abstract »
| Full Text »
| PDF »
- Necdin Regulates p53 Acetylation via Sirtuin1 to Modulate DNA Damage Response in Cortical Neurons.
- K. Hasegawa and K. Yoshikawa (2008)
J. Neurosci.
28, 8772-8784
| Abstract »
| Full Text »
| PDF »
- Quantitative Proteomics Analysis of the Effects of Ionizing Radiation in Wild Type and p53K317R Knock-in Mouse Thymocytes.
- L. M. Miller Jenkins, S. J. Mazur, M. Rossi, O. Gaidarenko, Y. Xu, and E. Appella (2008)
Mol. Cell. Proteomics
7, 716-727
| Abstract »
| Full Text »
| PDF »
- Acetylation in Nuclear Receptor Signaling and the Role of Sirtuins.
- C. Wang, M. J. Powell, V. M. Popov, and R. G. Pestell (2008)
Mol. Endocrinol.
22, 539-545
| Abstract »
| Full Text »
| PDF »
- An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2'-deoxycytidine Treatment.
- H. Wang, Y. Zhao, L. Li, M. A. McNutt, L. Wu, S. Lu, Y. Yu, W. Zhou, J. Feng, G. Chai, et al. (2008)
J. Biol. Chem.
283, 2564-2574
| Abstract »
| Full Text »
| PDF »
- Activation of p53 Function by Human Transcriptional Coactivator PC4: Role of Protein-Protein Interaction, DNA Bending, and Posttranslational Modifications.
- K. Batta and T. K. Kundu (2007)
Mol. Cell. Biol.
27, 7603-7614
| Abstract »
| Full Text »
| PDF »
- PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells.
- T.-C. Ho, S.-L. Chen, Y.-C. Yang, C.-L. Liao, H.-C. Cheng, and Y.-P. Tsao (2007)
Cardiovasc Res
76, 213-223
| Abstract »
| Full Text »
| PDF »
- Estrogen Receptor {alpha} Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis.
- A. Sayeed, S. D. Konduri, W. Liu, S. Bansal, F. Li, and G. M. Das (2007)
Cancer Res.
67, 7746-7755
| Abstract »
| Full Text »
| PDF »
- Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53.
- M. Reynolds and A. Zhitkovich (2007)
Carcinogenesis
28, 1613-1620
| Abstract »
| Full Text »
| PDF »
- The Lysine-specific Demethylase 1 Is Required for Cell Proliferation in Both p53-dependent and -independent Manners.
- A. Scoumanne and X. Chen (2007)
J. Biol. Chem.
282, 15471-15475
| Abstract »
| Full Text »
| PDF »
- Enhanced Deacetylation of p53 by the Anti-apoptotic Protein HSCO in Association with Histone Deacetylase 1.
- H. Higashitsuji, H. Higashitsuji, T. Masuda, Y. Liu, K. Itoh, and J. Fujita (2007)
J. Biol. Chem.
282, 13716-13725
| Abstract »
| Full Text »
| PDF »
- Site-specific Acetylation of p53 Directs Selective Transcription Complex Assembly.
- S. Roy and M. Tenniswood (2007)
J. Biol. Chem.
282, 4765-4771
| Abstract »
| Full Text »
| PDF »
- Outcomes of p53 activation - spoilt for choice.
- K. H. Vousden (2006)
J. Cell Sci.
119, 5015-5020
| Abstract »
| Full Text »
| PDF »
|
|